The influence of gender on the effects of aspirin in preventing myocardial infarction

BMC Medicine

Volumn 5, Issue , 2007, Pages

  Yerman, Todd ^a   Gan, Wen Q ^a   Sin, Don D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; ANTITHROMBOCYTIC AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; HEART INFARCTION; HUMAN; LINEAR REGRESSION ANALYSIS; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SEX DIFFERENCE; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; AGED; FEMALE; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; RISK; STATISTICAL MODEL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ASPIRIN; FEMALE; HUMANS; INCIDENCE; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; SEX FACTORS; TREATMENT OUTCOME;

EID: 36349026837     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-5-29     Document Type: Article

References (35)

1. Hayden M, Pignone M, Phillips C, Mulrow C: Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002, 136:161-172. 11790072
2. Gum PA, Kottke-Marchant K, Poggio ED, Gurm H, Welsh PA, Brooks L, Sapp SK, Topol EJ: Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001, 88:230-235. 10.1016/ S0002-9149(01)01631-9 11472699
3. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71-86. 64503 11786451 10.1136/bmj.324.7336.S71
4. Cho MK, Bero LA: Instruments for assessing the quality of drug studies published in the medical literature. JAMA 1994, 272:101-104. 10.1001/ jama.272.2.101 8015115
5. Persantine-Aspirin Reinfarction Study Research Group Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group. Circulation 1980, 62:449-461.
6. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980, 243:661-669. 10.1001/jama.243.7.661 6985998
7. Coronary Drug Project Research Group Aspirin in coronary heart disease. The Coronary Drug Project Research Group. Circulation 1980, 62:V59-62. 7002353
8. Swedish Cooperative High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study. Stroke 1987, 18:325-334. 2882626
9. Physicians' Health Study Research Group Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 1989, 321:129-135. 2664509
10. RISC Group Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group. Lancet 1990, 336:827-830. 10.1016/ 0140-6736(90)92336-G 1976875
11. SALT Collaborative Group Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group. Lancet 1991, 338:1345-1349. 10.1016/ 0140-6736(91)92233-R 1682734
12. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 1991, 84:527-539 1860198
13. EDTRS Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators. JAMA 1992, 268:1292-1300. 10.1001/jama.268.10.1292 1507375
14. EAFT Study Group Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 1993, 342:1255-1262. 7901582
15. MRC Thrombosis prevention trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet 1998, 351:233-241. 10.1016/S0140-6736(97)11475-1 9457092
16. Breddin K, Loew D, Lechner K, Oberla K, Walter E: The German-Austrian aspirin trial: A comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group. Circulation 1980, 62:V63-72. 6777073
17. Cairns JA, Gent M, Singer J, Finnie KJ, Froggatt GM, Holder DA, Jablonsky G, Kostuk WJ, Melendez LJ, Myers MG: Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med 1985, 313:1369-1375. 3903504
18. Cote R, Battista RN, Abrahamowicz M, Langlois Y, Bourque F, Mackey A: Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group. Ann Intern Med 1995, 123:649-655. 7574219
19. de Gaetano G: Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 2001, 357:89-95. 10.1016/ S0140-6736(00)03539-X 11197445
20. Elwood PC, Cochrane AL, Burr ML, Sweetnam PM, Williams G, Welsby E, Hughes SJ, Renton R: A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J 1974, 1:436-440. 1633246 4593555
21. Elwood PC, Sweetnam PM: Aspirin and secondary mortality after myocardial infarction. Lancet 1979, 2:1313-1315. 10.1016/S0140-6736(79)92808-3 92668
22. Farrell B, Godwin J, Richards S, Warlow C: The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: Final results. J Neurol Neurosurg Psychiatry 1991, 54:1044-1054. 1783914
23. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998, 351:1755-1762. 10.1016/S0140-6736(98)04311-6 9635947
24. Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R: Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet 1992, 340:1421-1425. 10.1016/0140-6736(92)92619-Q 1360557
25. Lewis HD, Jr Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE 3rd, Schnaper HW, LeWinter MM, Linares E, Pouget JM: Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med 1983, 309:396-403. 6135989
26. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE: A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005, 352:1293-1304. 10.1056/NEJMoa050613 15753114
27. Sorensen PS, Pedersen H, Marquardsen J, Petersson H, Heltberg A, Simonsen N, Munck O, Andersen LA: Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study. Stroke 1983, 14:15-22. 6337425
28. Sutton AJ, Abrams KR: Methods for meta-analysis in medical research. Chichester, UK: John Wiley 2000
29. Chen WH, Lee PY, Ng W, Tse HF, Lau CP: Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 2004, 43:1122-1126. 10.1016/j.jacc.2003.12.034 15028378
30. Lanne T, Ahlgren AR: Increased arterial stiffness in IDDM women - methodological considerations. Diabetologia 1996, 39:871-872. 10.1007/ s001250050527 8817117
31. Hu J, Norman M, Wallensteen M, Gennser G: Increased large arterial stiffness and impaired acetylcholine induced skin vasodilatation in women with previous gestational diabetes mellitus. Br J Obstet Gynaecol 1998, 105:1279-1287. 9883919
32. Pepine CJ, Kerensky RA, Lambert CR, Smith KM, von Mering GO, Sopko G, Bairey Merz CN: Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol 2006, 47(Suppl 3):S30-35. 10.1016/ j.jacc.2005.09.023
33. American Heart Association. Heart Disease and Stroke Statistics: 2005 Update Dallas, TX: American Heart Association; 2005
34. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM: Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999, 341:217-225. 10.1056/NEJM199907223410401 10413733
35. Sanderson S,AEmery J, Baglin T, Kinmonth AL: Narrative review: aspirin resistance and its clinical implications. Ann Intern Med 2005, 142:370-380. 15738456